Sana Biotechnology, Inc.
- Last sale
- Nov 12, 2026 · -13.04%
- Market cap
- $599.27M
- 299.63M shares
- Filings
- 392
—
—
—Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−43.7% FY25 yoy
- $599.27M
- —
- —
- 3.3×
- -24.16%
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $131,980,000 | reported | |
| FY 2024 | 2024-12-31 | $215,673,000 revised | reported | |
| FY 2023 | 2023-12-31 | $261,809,000 revised | reported | |
| FY 2022 | 2022-12-31 | $285,885,000 | reported | |
| FY 2021 | 2021-12-31 | $248,626,000 | reported | |
| FY 2020 | 2020-12-31 | $132,944,000 | reported | |
| FY 2019 | 2019-12-31 | $99,591,000 | reported |
Biological products, except diagnostic substances
Sana Biotechnology, Inc. is the 60th largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836
CompanyRevenueGrowthNet marginMarket cap
CGEMCullinan Therapeutics, Inc.———$661.5MDNAGinkgo Bioworks Holdings, Inc.$170.2M25.1%183.8%$658.8MCADLCandel Therapeutics, Inc.———$658.2MGRMLGreenland Mines Ltd———$612.4MSRZNSurrozen, Inc.$3.5M67.4%6,960.8%$605.8M
SANASana Biotechnology, Inc. (this company)———$599.3M
ETRAElectra Therapeutics, Inc.———$574.6MENTXEntera Bio Ltd.$42.0K76.8%27,235.7%$559.9MRGNXRegenxbio Inc.$170.4M104.5%113.8%$531.0MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Sana Biotechnology, Inc. · CIK 1770121 · Engraved from SEC EDGAR